Biotechnology
Company Overview of Biolex Therapeutics, Inc.
Executive Profile
Mark F. Witcher Ph.D.Member of Development Advisory Board, Biolex Therapeutics, Inc. |
| Age | Total Calculated Compensation | This person is connected to 1 Board Members in 1 different organizations across 0 different industries. See Board Relationships |
| -- | -- |
Background
Mark F. Witcher Ph.D. serves as a Member of Development Advisory Board of Biolex Incorporated. Dr. Witcher currently serves as a Consultant in biopharmaceutical operations to international biotechnology and pharmaceutical companies. His previous positions included Vice President of Manufacturing for MERIX Bioscience, Inc. and Senior Vice President of Manufacturing Operations for Covance Biotechnology Services (now Diosynth RTP, Inc.). Dr. Witcher joined Amgen in 1986 ...
Corporate Headquarters158 Credle StreetPittsboro, North Carolina 27312 United States Phone: 919-542-9901 Fax: 919-542-9910 Board Members MembershipsThere is no Board Members Memberships data available.EducationPhD University of Massachusetts, Amherst
Other Affiliations |
Annual CompensationThere is no Annual Compensation data available.Stocks OptionsThere is no Stock Options data available.Total CompensationThere is no Total Compensation data available. |
COMPETITOR COMPENSATION
| There is no Competitor Compensation data available. |
Post a JobJobs
- Adelphi, MD | University of Maryland University CollegePosted: May 07
- Milwaukee, WI | Robert W. BairdPosted: Apr 19
- Kennebunk, ME | CorningPosted: May 24
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
Sponsored Financial Commentaries
Sponsored Links
To contact Biolex Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








